INS and pancreatic adenocarcinoma: The islet cell hyperplasia seen with compound 149 might be related to the pancreatic adenocarcinoma seen with compound 167. A pharmacological target in the pancreas for this class is well known to be inhibitory, e.g., inhibiting insulin secretion.